drugset / Trial / NCT07081256
To Evaluate the Efficacy and Safety of QLM2010 for Prevention of Chemotherapy-induced Nausea and Vomiting After Highly Emetogenic Chemotherapy.
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Compared With Fosaprepitant dimeglumine for Injection and Palonosetron Hydrochloride Injection, to Evaluate the Efficacy and Safety of QLM2010 for Injection for Prevention of Chemotherapy-induced Nausea and Vomiting After Highly Emetogenic Chemotherapy.
Timeline
- Start
- 2025-01-03
- Primary completion
- 2025-08-25
- Completion
- 2025-10-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Palonosetron | Other / unclassified | — | — |
| Subject | QLM2010 | Unknown | — | — |
| Comparator | fosaprepitant dimeglumine | Unknown | — | — |
| Background | Dexamethasone | Small molecule | — | — |